神经退行性疾病:表观遗传调节机制和治疗潜力
Jianbing Men1, Xinyue Wang1, Yunnuo Zhou1
1Department of Toxicology, School of Public Health, Shenyang Medical College, Shenyang 110034, PR China.
Cellular signalling
|March 15, 2025
概括
表观遗传修饰,包括DNA甲基化和基因素变化,在神经退行性疾病 (NDD) 中起着至关重要的作用. 了解这些表观遗传机制为阿尔茨海默氏症和帕金森病等疾病的新诊断和治疗策略提供了潜力.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 分子生物学分子生物学
背景情况:
- 神经退行性疾病 (NDD) 涉及渐进的神经元损失和功能障碍.
- NDDs的发病与遗传因素,氧化应激,亡和免疫反应有关.
- 表观遗传调节影响基因转录和神经系统功能.
研究的目的:
- 审查表观遗传修饰在NDD发病过程中的作用.
- 总结NDD中由表观遗传机制调节的关键基因.
- 讨论表观遗传学在NDD诊断和治疗中的临床应用.
主要方法:
- 文献综述侧重于NDD中的表观遗传机制.
- 对DNA甲基化,基因素修饰和非编码RNA研究的分析.
- 综合目前关于表观遗传学和NDDs的研究.
主要成果:
- 表观遗传修饰是NDD发展和进展的组成部分.
- 参与NDDs的特定基因由DNA甲基化,基因素修饰和非编码RNAs进行调节.
- 表观遗传调节的失衡与NDD发生有关.
结论:
- 表观遗传学是神经退行性疾病的发病的一个关键因素.
- 表观遗传修饰在NDD中提出了临床诊断和治疗的潜在目标.
- 对表观遗传机制的进一步研究可以促进对NDD的理解和治疗.
相关概念视频
Epigenetic Regulation
30.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.8K
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Overview
410
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
410
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K


